International Stem Cell Corporation Completes Clinical Testing of a New Compound – CNNMoney

International Stem Cell Corporation Completes Clinical Testing of a New CompoundCNNMoneyInternational Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, anno...
http://blog.zandcell.com/international-stem-cell-corporation-completes-clinical-testing-of-a-new-compound-cnnmoney/